Improving a Drug for Managing Schizophrenia…Heather Turner, CEO, LB Pharmaceuticals
From BioTech Nation ... with Dr. Moira Gunn · · 19 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
This week on Biotech Nation, Heather Turner of LB Pharmaceuticals joins to discuss a drug that’s new to the US, but not-so-new to Europe, where it’s already been in use for a couple of years. Intended for managing neuropsychiatric conditions like Schizophrenia, the drug is taken by several million people, but the approval process in the US has had to start back at square one. We look at why that is, and how LB is working on it.
Back to BioTech Nation ... with Dr. Moira Gunn · Report a problem